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Abstract  
AIM: To determine the risk factors associated with H. pylori infection and possible correlation with 
clinicopathological parameters. 
MATERIAL AND METHODS: Gastroduodenal biopsies were examined by rapid urease test and 
Gram staining. Cag A cytotoxin was detected by in situ hybridization. 
RESULTS: Risk of H. pylori acquisition reported as following: Males have 1.38 fold, rural residents 
have 0.63 fold, Nonsmokers have 0.39 fold, mild smokers have 18 fold, and moderate smokers 
have 1.4 fold while heavy smokers have 1 fold. A person who’s in contact with animals has 1.52 
fold risks. Illiterates and patients with primary education have 5.36 & 3 fold risk respectively. Pa-
tients under proton pump inhibitor (PPI) therapy have 1.02 fold. Patients under NSAID therapy have 
3.48 fold while nonalcoholic Patients have 0.75 fold. Patients using tap water have 0.45 fold risk. H. 
pylori infection positively correlated with age, weight loss, and heartburn. H. pylori inversely corre-
lated with endoscopic diagnosis, Cag A positivity, and education level. Cag A positivity correlated 
with animal contact and NSAID usage.  
CONCLUSIONS: Several life style factors, education, animal contact, using of PPI, and NSAIDs 
increase the risk of H. pylori infection. Weight loss and heartburn cardinal signs for H. pylori infec-
tion. Endoscopic diagnosis and clinicopathological parameters not strictly associated with Cag A 
positivity. 
 
 
 
 
 
 
Introduction 
 
Helicobacter pylori infection is conventional 
chronic bacterial infection around the world [1]. The 
pathogen is the most common cause of morbidity and 
mortality in upper digestive tract diseases and has a 
strong association with a variety of gastric patholo-
gies, including type B antral gastritis, peptic ulcer, 
gastric MALT lymphoma, and gastric adenocarcinoma 
[2, 3].  
Extra-alimentary ailments such as coronary 
disease, myocardial infarction, migraine, dermatologi-
cal disorders, iron deficiency anemia, and some auto-
immune diseases also developed due to H. pylori [4]. 
It has been shown that 50% adult in developed coun-
tries and 90% adults in developing countries were 
positive of serum antibodies against H. pylori [4]. The 
critical period at which H. pylori is acquired, is during 
the childhood, especially in the developing countries 
and areas of overcrowding and socioeconomic depri-
vation [5].  
H. pylori have developed a repertoire of func-
tions for survival in the harsh gastric niche, including 
acid tolerance, motility, adherence, immune evasion 
and mechanisms for adaptive evolution. These fea-
tures are all involved in the interplay between the host 
and the bacterium and may influence acquisition and 
persistence of infection. Bacterial acid tolerance and 
motility play critical role in gastric colonization [6]. The 
Objective of this study was to determine the risk fac-
tors associated with H. pylori infection and possible 
correlations between Clinicopathological parameters 
with these risk factors. 
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Material and Methods 
 
Patients 
In this cross sectional, hospital based study, 
106 patients, age range 15-80 years, mean ± SD 
(44.70 ± 18.260) with clinical indications for 
gastroduodenoscopy during February 2013 to June 
2014 were studied. This study conducted according to 
the principles of Helsinki declaration. Dully-filled con-
sent form obtained from all patients before endoscopy 
in Gastroenterology Department of Baqubah Teaching 
Hospital in Diyala Province - Iraq. Approval of ethical 
review Committee of College of Medicine, Diyala Uni-
versity, Iraq; taken prior to initiation of the work. Pa-
tients were excluded in the following circumstances: 
having a history of previous gastric surgery, recent or 
active gastrointestinal bleeding, patients with treated 
with antibiotics or colloidal bismuth compounds for 
past one month, if the informed consent was not ob-
tained [7]. 
 
Methods  
After topical pharyngeal anesthesia for over-
night fasted Patients, A sterile flexible endoscope in-
troduced for full investigation of Stomach and duode-
num. Six endoscopic biopsies obtained from con-
gested, inflamed or erosive lesions via sterile biopsy 
forceps. The samples for Gram staining procedure 
were retired from the biopsy forceps using a sterile 
needle, and placed in an Eppendorf tube containing 
0.5 mL of sterile saline as a means of transportation 
[7]. Samples for rapid urease test placed in separate 
vial, previously identified, containing the appropriate 
medium for test.  
The RUT performed. This test was performed 
with a homemade solution with 1 ml distilled water, 
one drop of 1% phenol red (pH = 6.5), and 100 mg 
urea, prepared just before endoscopy. One antral 
sample placed in the solution and tube then incubated 
at 37°C. The test considered positive when the color 
changed from yellow, pink to red within 24 hours [8]. 
Biopsy sample placed in sterile glass slide with a drop 
of normal saline and teased with sterile scalpel to 
make smaller fragments of tissue then another sterile 
glass slide was placed over the teased first tissue and 
the tissue was crushed between the two glasses then 
stain by Gram’s staining. Existence of Gram negative 
spiral bacteria embedded in the tissue cells was diag-
nostic for H. Pylori [9]. true positive results were con-
sidered if a combination of urease test and Gram stain 
give positive results for a single biopsy specimen [10]. 
H pylori cytotoxin-associated gene A (CagA) was de-
termined using biotinylated DNA probe (H. pylori / 
CagA Gene, Cat. No.: IH-60061, (Maximbiotech prod-
uct Catalog # SP-10216) as previously described [7]. 
The dependent Scoring system for smoking habits 
(non-smoker = 0 cigarette per day; mild smoker = 10 
cigarette per day; moderate smoker = 11-20 cigarette 
per day; heavy smoker = ˃20 cigarette per day) [11]. 
Scoring system for patients education (Illiteracy; pri-
mary; secondary; university) [11]. The dependent 
Scoring system for Epigastric pain (negative, mild, 
moderate) and for heart burn (negative, mild, moder-
ate) according to [12] with modification. 
 
Statistical analysis 
Data analysis performed using the following 
tests: Frequency of variables express as percentage. 
Pepsinogen I, II and gastrin values express as mean ± 
standard deviation, (Mean ± SD). Chi square and 
Pearson test for correlation used for non-categorical 
data. Estimated risk (Odd ratio) and the corresponding 
95% confidence intervals for all tests were calculated 
using MedCalc statistical software, Version 13.1.1, 
Belgium. The level of significance was 0.05 (two-tail) 
in all statistical testing; significant of correlations 
include also 0.01 (two-tail). Statistical analysis was 
performed using also SPSS for windows TM version 
17.0, and Microsoft EXCEL for windows 2010.  
 
Results 
Demographic features of 106 patients are 
shown in Table 1.  
Table 1: Demographic Risk Factors for H. pylori infection 
Age (years) 
H. pylori test Estimated risk 
X2P value 
Correlation among 
H. pylori and risk 
factors 
Correlation among H. 
pylori Cag A cytotoxin 
and risk factors 
H. pylori Positive 
H. pylori 
Negative 
Total No. (%) Odd ratio 
95% Confidence 
Interval 
Total positive 
Cag A 
cytotoxin 
positive 
Cag A 
cytotoxin 
negative 
r P value r P value 
15-23 3 (2.83%) 2 (1.88%) 1 (0.94%) 5 (4.72%) 8 (7.55%) 0.64 0.0101- 40.0759 
0.037*** 0.229* 0.018 0.131 0.181 
24-32 16 (15.09%) 8 (7.55%) 8 (7.55%) 7 (6.60%) 23 (21.70%) 2.2 0.0397 - 121.7979 
33-41 24 (22.64%) 17 (16.04%) 7 (6.60%) 6 (5.66%) 30 (28.30%) 3.77 0.0681 - 208.7469 
42-50 8 (7.55%) 5 (4.72%) 3 (2.83%) 2 (1.89%) 10 (9.43%) 3.4 0.0528- 219.1394 
51-59 7 (6.60%) 2 (1.88%) 5 (4.72%) 3 (2.83%) 10 (9.43%) 2.14 0.0348 -131.9417 
60-68 4 (3.77%) 2 (1.88%) 2 (1.88%) 1 (0.94%) 5 (4.72%) 3 0.0394 -228.6827 
69-77 15 (14.15%) 9 (8.49%) 6 (5.66%) 2 (1.89%) 17 (16.04%) 6.20 0.0986- 389.9085 
78-86 3 (2.83%) 3 (2.83%) 0 (0%) 0 (0%) 3 (2.83%) 7 0.0514 - 953.2624 
Total 80 (75.47%) 48 (45.3%) 32 (30.19%) 26 (24.53%) 106 (100%)   
Gender 
Male 43 (40.57%) 29 (27.4%) 14 (13.21%) 16 (15.09%) 59 (55.7%) 
1.38 0.557-3.40 0.24 0.067 0.492 -0.087 0.375 
Female 37 (34.91%) 19 (17.92%) 18 (16.98%) 10 (9.43%) 47 (44.3%) 
Residence  
Rural 46 (43.39%) 28 18 (16.98%) 12 (11.32%) 58 (54.7%) 
0.63 0.260-1.54 0.33 -0.098 0.317 -0.066 501 
Urban 34 (32.08%) 20 (18.87%) 14 (13.21%) 14 (13.21%) 48 (45.3%) 
 
*Correlation is significant at the 0.05 level (2-tailed); ** Correlation is significant at the 0.01 level (2-tailed); *** ANOVA. 
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Table 2: Education and Behavioral Risk Factors for H. pylori infection 
 
Parameters 
H. pylori test Estimated risk  
X2  
P value 
Correlation among H. 
pylori and risk factors 
Correlation among 
H. pylori Cag A 
cytotoxin and risk 
factors 
H. pylori Positive 
H. pylori 
Negative 
Total No. (%) 
Odd 
ratio 
95% Confidence 
Interval 
Total posi-
tive 
Cag A 
cytotoxin 
positive 
Cag A 
cytotoxin 
negative 
r P value r P value 
Education 
level 
Illiteracy 29 (27.36%) 20 (18.87%) 9 (8.49%) 5 (4.72%) 34 (32.1%) 5.36 0.0959 - 300.0519 
0.16 -0.225* 0.020 -0.331 0.001 Primary 16 (15.09%) 13 (12.26%) 3 (2.83%) 2 (1.89%) 18 (17.0%) 3 0.150-59.890 
Secondary 19 (17.92%) 10 (9.43%) 9 (8.49%) 10 (9.43%) 29 (27.4%) 0.42 0.040-4.334 
University 16 (15.09%) 5 (4.72%) 11 (10.38%) 9 (8.49%) 25 (23.6%) 1.24 0.166-9.253      
Smoking 
Nonsmoker 50 (47.17%) 31 (29.2%) 19 (17.92%) 17 (16.04%) 67 (63.2%) 0.39 0.112-1.73 
0.000 -0.030 0.764 -0.077 0.436 
Mild smoker 22 (20.75%) 14 (13.21%) 8 (7.55%) 5 (4.72%) 27 (25.5%) 18 1.562-207 
Moderate smoker 7 (6.60%) 2 (1.88%) 5 (4.72%) 3 (2.83%) 10 (9.4%) 1.4 0.876-2.237 
Heavy smoker 1 (0.94%) 1 (0.94%) 0 (0%) 1 (0.94%) 2 (1.9%) 1 0.0108 - 92.4276 
Animal 
contact 
Positive 25 (23.58%) 22 (20.75%) 3 (2.83%) 6 (5.66%) 31 (29.2%) 
1.52 0.542-4.23 0.000 0.077 0.431 0.332 0.001 
Negative 55 (51.89%) 26 (24.53%) 29 (27.4%) 20 (18.87%) 75 (70.8%) 
D
ru
g
s
 PPI 
Negative 71 (66.98%) 40 (37.74%) 31 (29.2%) 23 (21.70%) 94 (88.7%) 
1.02 0.242-3.897 0.000 -0.004 0.968 0.153 0.116 
Positive 9 (8.49%) 8 (7.55%) 1 (0.94%) 3 (2.83%) 12 (11.3%) 
NSAID 
Negative 62 (58.49%) 34 (32.1%) 28 (26.42%) 24 (22.64%) 86 (81.1%) 
3.48 0.751-16.169 0.000 0.163 0.095 0.239 0.01 
Positive 18 (16.98%) 14 (13.21%) 4 (3.77%) 2 (1.89%) 20 (18.9%) 
Alcohol 
Negative 79 (74.52%) 57 (53.77%) 22 (20.75%) 26 (24.53%) 105 (99.1%) 
0.75 0.674-0.840 0.000 0.056 0.056 -0.089 0.365 
Positive 1 (0.94%) 1 (0.94%) 0 (0%) 0 (0%) 1 (0.9%) 
Water 
source 
Spigot water 74 (69.81%) 43 (40.57%) 31 (29.2%) 22 (20.75%) 96 (90.6%) 
0.45 0.115-1.72 0.000 -0.116 0.236 0.031 0.756 
Filtrated water 6 (5.66%) 5 (4.72%) 1 (0.94%) 4 (3.77%) 10 (9.4%) 
 
*Correlation is significant at the 0.05 level (2-tailed); ** Correlation is significant at the 0.01 level (2-tailed). 
 
Significant difference was detected among 
age groups in H. pylori infection (p < 0.001). Signifi-
cant positive correlation was reported between age 
groups and H. pylori infection (r = 0.229, p value = 
0.018). While no significant correlation was reported 
between age groups and infection with Cag A cyto-
toxin producing H. pylori (r = 0.131, p value = 0.181) 
as shown in Table 1. Males represent 55.7% vs. fe-
males 44.3% (Table 1). Males have 1.38 fold risk of H. 
pylori acquisition compared with females without sig-
nificant difference between males and females in-
fected with H. pylori (p ˃ 0.05). There was no signifi-
cant correlation between H. pylori infection and gen-
der of patient (r = 0.067, p value = 0.492). No signifi-
cant correlation was reported between gender and 
infection with Cag A cytotoxin producing H. pylori (r= -
0.087, p value = 0.375). 
 Residence in rural was 54.7% vs. 45.3% in urban 
areas. Peoples residence in rural areas have 0.63 fold 
risk of H. pylori acquisition compared with those from 
urban without significant difference between patients 
from rural and urban areas infected with H. pylori (p ˃ 
0.05). There was no significant correlation between H. 
pylori infection and residence of patient (r = -0.098, p 
value = 0.317) (Table 1). No significant correlation 
was reported between residence and infection with H. 
pylori Cag A positive (r = -0.066, p value = 501) as 
shown in Table 1. 
Education and behavioral risk factors for H. 
pylori infection are shown in Table 2. Regarding edu-
cation level 27.36% of H. pylori, positive cases were 
illiterate, 15.09% primary education and university 
education; 17.92% finished secondary education. Illit-
erates and patients with primary education have 5.36 
& 3 fold risk for acquisition of H. pylori infection. While 
those at secondary and university education level 
have, 0.42 and 1.24 fold risk respectively without sig-
nificant differences (p ˃ 0.05). Inverse correlation be-
tween H. pylori infection and education levels of pa-
tients was detected (r = -0.225, p value = 0.020). In-
verse significant correlation between H. pylori Cag A 
positive and education levels (r = -0.331, p value = 
0.001) as shown in Table 2. 
Nonsmokers represent 63.2%, 25.5% mild, 
9.4% moderate, 1.9% heavy smokers, respectively. 
Nonsmoker have 0.39 fold risk for H. pylori acquisi-
tion, mild smokers have 18 fold risk, moderate smok-
ers have 1.4 fold risk while heavy smokers have 1 fold 
risk of H. pylori acquisition. There was significant dif-
ference between smoker patients infected with H. py-
lori (p ˂ 0.05). No significant correlation between H. 
pylori infection and smoking (r = -0.030, p value = 
0.764) (Table 2). No significant correlation was re-
ported between smoking and infection with H. pylori 
Cag A positive (r = -0.077, p value = 0.436). 
Table 3: Distribution of Endoscopic diagnosis according to patient’s age 
Age 
(Years) 
Endoscopic diagnosis 
Gastric ulcer Gastritis Gastropathy Duodenal ulcer Duodenitis Total H.pylori 
Total no. of 
patients  H. pylori  
+ve 
 H. pylori 
 -ve 
H. pylori  
+ve 
 H. pylori 
 -ve 
H. pylori  
+ ve 
 H. pylori  
-ve 
H. pylori  
+ve 
 H. pylori 
 -ve 
H. pylori  
+ve 
 H. pylori 
 -ve 
Positive  Negative  
15-23 0 (0%) 0 (0%) 1 (0.94%) 2 (1.89%) 2 (1.89%) 2 (1.89%) 0 (0%) 1 (0.94%) 0 (0%) 0 (0%) 3 (2.83%) 5 (4.72%) 8 (7.55%) 
24-32 3 (2.83%) 0 (0%) 5 (4.72%) 3 (2.83%) 1 (0.94%) 4 (3.77%) 4 (3.77%) 0 (0%) 3 (2.83%) 0 (0%) 16 (15.09%) 7 (6.60%) 23 (21.70%) 
33-41 1 (0.94%) 1 (0.94%) 8 (7.55%) 3 (2.83%) 11 (10.37%) 2 (1.89%) 3 (2.83%) 0 (0%) 1 (0.94%) 0 (0%) 24 (22.64%) 6 (5.66%) 30 (28.30%) 
42-50 2 (1.88%) 0 (0%) 3 (2.83%) 1 (0.94%) 4 (3.77%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 8 (7.55%) 2 (1.89%) 10 (9.43%) 
51-59 1 (0.94%) 1 (0.94%) 5 (5.66%) 1 (0.94%) 0 (0%) 2 (1.89%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 7 (6.60%) 3 (2.83%) 10 (9.43%) 
60-68 2 (1.88%) 0 (0%) 0 (0%) 1 (0.94%) 1 (0.94%) 0 (0%) 0 (0%) 0 (0%) 1 (0.94%) 0 (0%) 4 (3.77%) 1 (0.94%) 5 (4.72%) 
69-77 7 (6.60%) 0 (0%) 5 (4.72%) 2 (1.89%) 0 (0%) 0 (0%) 2 (1.89%) 0 (0%) 1 (0.94%) 0 (0%) 15 (14.15%) 2 (1.89%) 17 (16.04%) 
78-86 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 3 (2.83%) 0 (0%) 0 (0%) 0 (0%) 3 (2.83%) 0 (0%) 3 (2.83%) 
Total 
16 (15.09%) 2(1.89%) 27 (25.47%) 13 (12.26%) 19 (17.92%) 10 (9.43%) 12 (12.26%) 1 (0.94%) 6 (5.66%) 0 (0%) 80 (75.47%) 26 (24.53%) 106 (100%) 
18 (16.98%) 40 (37.74%) 29 (27.36%) 13 (12.26%) 6 (5.66%) 106 (100%) 
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Patients usually in contact with animals repre-
sent 29.2% among them 23.58% proved to have H. 
pylori infection, while 51.89% of patients with positive 
H. pylori have no contacts with animals. Peoples who 
are in contact with animals have 1.52 fold risk of H. 
pylori acquisition compared with those who do not in 
direct contact with animals with significant differences 
(p ˂ 0.05). No significant correlation between H. pylori 
infection and contact with animals (r=0.077, p 
value=0.431) was found (Table 2). Significant correla-
tion was reported between contact with animals and 
infection with H. pylori Cag A positive (r = 0.332, p 
value = 0.001). 
As shown in Table 2, a total of 66.98% of pa-
tients with positive H. pylori never administrates pro-
ton pump inhibitor (PPI) and 8.49% of patients with 
history of PPI administration. Patients under PPI ther-
apy have 1.02 fold to get H. pylori infection compared 
with those do not use PPI with significant difference (p 
˂ 0.05). No correlation between PPI administration 
and H. pylori infection (r = -0.004, p value = 0.968) 
(Table 1). No correlation was reported between PPI 
administration and infection with H. pylori Cag A posi-
tive (r = 0.153, p value = 0.116).  
A total of 62 (58.49%) of patients with positive 
H. pylori never administrates NSAID and 24 (22.64%) 
of patients with history of NSAID administration. Pa-
tients under NSAID therapy have 3.48 fold to get H. 
pylori infection compared with those dot use NSAID 
with significant difference (p ˂ 0.05). No significant 
correlation between NSAID administration and H. py-
lori infection (r = -0.163, p value = 0.095). Signi-ficant 
correlation reported between NSAID admini-stration 
and infection with H. pylori Cag A positive (r = 0.239, p 
value = 0.01), as shown in Table 2. 
A total of 74.52% of patients with positive H. 
pylori never administrates alcohol and 24.53% with 
history of alcohol intake. Non alcoholics have 0.75 fold 
to get H. pylori infection compared with alcoholics with 
significant difference (p ˂ 0.05). No significant correla-
tion between alcohol intake and H. pylori infection (r = 
0.056, p value = 0.056). No significant correlation was 
reported between alcohol intake and infection with H. 
pylori Cag A positive (r = -0.089, p value = 0.365) as 
shown in Table 2.  
A total of 69.81% of patients with positive H. 
pylori administrates spigot water and 20.75% with 
spigot water administration give negative results. Pa-
tients administrates spigot water have 0.45 fold to get 
H. pylori infection compared with filtrated water with 
significant difference (p ˂ 0.05). No significant correla-
tion between spigot water administration and H. pylori 
infection (r = -0.116, p value = 0.236) as shown in Ta-
ble 2. No significant correlation was reported between 
spigot water administration and infection with H. pylori 
Cag A positive(r = 0.031, p value = 0.756). 
As shown in Table 3, Gastritis was detected in 
37.7%, gastropathy 27.36%, gastric ulcer 16.98%, 
duodenal ulcer 12.26%, and Duodenitis 5.7% of total 
patients (Table 3). As shown in Table 3, H. pylori in-
fection was detected in 22.64% in 33-41 years, the 
main clinical presentation was gastropathy 10.37% 
and gastritis 7.55% and they have 3.77 fold risks to 
get infection than those with H. pylori negative gas-
tropathy or gastritis. Cag A cytotoxin was detected 
insitu in 16.04% of H. pylori positive cases. The sec-
ond age group in H. pylori exposure was 24-32 years, 
15.09%, presented with gastritis 4.72% and gastropa-
thy 3.77% (Table 2). They have 2.2 fold risks to get 
infection than those with H. pylori negative gastropa-
thy or gastritis in the same age group. Cag A cytotoxin 
detected in 7.55% of H. pylori positive cases. 
 
Table 4: Predictive clinical symptoms and major complains for H. pylori infection 
Parameters No. (%) 
H. pylori test 
X2 
p value 
Correlation with H. 
pylori 
Correlation with H. 
pylori Cag A cytotoxin  
Positive 
Total H. pylori 
Negative 
r P value r P value Total H. pylori 
positive 
Cag A cytotoxin 
positive  
 Cag A cytotoxin 
negative  
Previous Medical History 
Negative history 55 (51.9%) 37 (34.91%) 19 (17.92%) 18 (16.98%) 18 (16.98%) 
0.000 0.093 0.34 0.162 0.097 
Gastritis 31 (29.2%) 27 (25.5%) 17 (16.04%) 10 (9.43%) 4 (3.77%) 
Gastric ulcer 7 (6.6%) 6 (5.66%) 6 (5.66%) 0 (0%) 1 (0.94%) 
Duodenitis 8 (7.5%) 7 (6.60%) 3 (2.83%) 4 (3.77%) 1 (0.94%) 
Duodenal ulcer 5 (4.7%) 3 (2.8%) 3 (2.83%) 0 (0%) 2 (1.89%) 
Total 106 (100%) 80 (75.47%) 48 (45.28%) 32 (30.19%) 26 (24.53%) 
M
a
jo
r 
C
o
m
p
la
in
s
 
Weight loss 
Positive 40 (37.7%) 37 (34.91%) 29 (27.36%) 11 (10.38%) 3 (2.83%) 
0.012 0.308** 0.001 0.426* 0.000 
Negative 66 (62.3%) 43 (40.57%) 19 (17.92%) 24 (22.64%) 23 (21.7%) 
Heartburn 
Negative 22 (20.8%) 14 (13.21%) 11 (10.38%) 3 (2.83%) 8 (7.55%) 
0.000 0.200* 0.040 0.104 0.289 Mild 75 (70.8%) 57 (53.77%) 29 (27.36%) 28 (26.42%) 18 (16.98%) 
Moderate 9 (8.5%) 9 (8.49%) 8 (7.55%) 1 (0.94%) 0 (0%) 
Epigastric pain 
Negative 10 (9.4%) 6 (5.66%) 5 ( 4.7%) 1 (0.94%) 4 (3.77%) 
0.000 0.154 0.114 0.068 0.487 Mild 47 (44.3%) 34 (32.08%) 18 (16.98%) 16 (15.09%) 13 (12.26%) 
Moderate 49 (46.2%) 40 (37.74%) 25 (23.58%) 15 (14.15%) 9 (8.49%) 
Iron deficiency 
anemia 
Negative 83 (78.3%) 60 (56.60%) 34 (32.1%) 26 (24.53%) 23 (21.70%) 
0.000 0.141 0.151 0.165 0.091 
Positive 23 (21.7%) 20 (18.86%) 14 (13.21%) 6 (5.66%) 3 (2.83%) 
Nausea 
Negative 33 (31.1%) 23 (21.70%) 16 (15.09%) 7 (6.60%) 10 (9.43%) 
0.000 0.090 0.358 -0.043 0.660 
Positive 73 (68.9%) 57 (53.77%) 32 (30.19%) 25 (23.58%) 16 (15.09%) 
Bloating 
Negative 79 (74.5%) 63 (59.43%) 38 (35.85%) 25 (23.58%) 16 (15.09%) 
0.000 0.093 0.341 -0.097 0.323 
Mild 27 (25.5%) 17 (16.04%) 10 (9.43%) 7 (6.60%) 10 (9.43%) 
*Correlation is significant at the 0.05 level (2-tailed);** Correlation is significant at the 0.01 level (2-tailed). 
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The third more exposed age group was 69-77 
years in which H. pylori detected in 14.15% mostly 
with gastric ulcer 6.60% and gastritis 4.72%. They 
have 6.20 fold risks to get infection than those with H. 
pylori negative gastric ulcer or gastritis in the same 
age group. Cag A cytotoxin was detected in 8.49% of 
H. pylori positive cases. H. pylori Infection detected 
among 42-50 years in 7.55%, mostly with gastropathy 
3.77% and gastritis 2.83%. They have 3.4 fold risks to 
get infection than those with H. pylori negative gas-
tropathy or gastritis in the same age group. Cag A 
cytotoxin detected in 4.72% of H. pylori positive 
cases. H. pylori Infection detected among 51-59 years 
in 6.60%, mostly with gastritis 5.66%. They have 2.14 
fold risk to get infection than those with H. pylori nega-
tive gastritis in the same age group. Cag A cytotoxin 
was detected in 1.88% of H. pylori positive cases. Old 
age (78-86) years was presented with duodenal ulcer 
2.83%, they have 7 fold risk to get infection than those 
with H. pylori negative gastritis. Cag A cytotoxin de-
tected in 2.83% of H. pylori positive cases. 
As shown in Table 4, H. pylori detected in 
34.91% in patients have no previous gastric medical 
history, 25.5% in patients previously suffered from 
gastritis, gastric ulcer 5.66%, duodenitis 6.60%, duo-
denal ulcer 2.8%. Significant difference between 
groups regarding H. pylori positivity (p value < 0.001), 
No significant correlation between previous medical 
history and recent H. pylori Infections (r = 0.093, p 
value = 0.34). No significant correlation reported be-
tween previous medical history and infection with H. 
pylori Cag A positive (r = 0.162, p value = 0.097). Pa-
tients come with major complains, weight loss repre-
sent 37.7%, mild heat burn 70.8%, moderate 8.5%, 
mild epigastric pain 44.3%, moderate 46.2%, anemia 
21.7%, nausea 68.9%, mild bloating 25.5%, as shown 
in Table 4. 
A total 34.91% of patients with positive H. py-
lori suffered from weight loss while 40.57% of H. pylori 
positive cases never complain weight loss with signifi-
cant difference (p ˂ 0.05). Significant correlation re-
ported between weight loss and H. pylori infection (r = 
0.308, p value = 0.001). Significant correlation re-
ported between weight loss and infection with H. pylori 
Cag A positive (r = 0.426, p value < 0.001), as shown 
in Table 4.  
H. pylori positive patients presented with no 
history of heartburn represent 13.21%, 53.77% for 
mild and 8.49% for moderate heart burn with signifi-
cant difference (p ˂ 0.05) and correlation between 
heartburn and H. pylori infection (r = 0.200, p value = 
0.040). No correlation reported between heartburn 
and infection with H. pylori Cag A positive (r = 0.104, p 
value = 0.289). H. pylori positive patients presented 
with no history of epigastric pain represent 5.66%, 
32.08% for mild and 37.74% for moderate epigastric 
pain with significant difference (p ˂ 0.05). No correla-
tion between epigastric pain and H. pylori infection (r = 
0.154, p value = 0.114). No correlation reported be-
tween epigastric pain and infection with H. pylori Cag 
A positive (r = 0.068, p value = 0.487). H. pylori posi-
tive patients presented with no history of anemia rep-
resent 56.60% and 18.86% of patients with positive H. 
pylori presented with anemia with significant differ-
ence (p ˂ 0.05) but without correlation between ane-
mia and H. pylori infection (r = 0.141, p value = 
0.151). No correlation reported between anemia and 
infection with H. pylori Cag A positive (r = 0.165, p 
value = 0.091). H. pylori positive patients presented 
with no history of nausea represent 21.70% and 
53.77% of patients with positive H. pylori presented 
with nausea with significant difference (p ˂ 0.05), 
without correlation between nausea and H. pylori in-
fection (r = 0.090, p value = 0.358). No correlation 
reported between nausea and infection with H. pylori 
Cag A positive (r = -0.043, p value = 0.660). H. pylori 
positive patients presented with no history of bloating 
represent 59.43% and 16.04% of patients with posi-
tive H. pylori presented with mild bloating with signifi-
cant difference (p ˂ 0.05), without correlation between 
bloating and H. pylori infection (r = 0.093, p value = 
0.341).  
  
 
Table 5: Predictive endoscopic and diagnostic findings for H. pylori infection 
Parameters No. (%) 
H. pylori test 
X2 
p value 
Correlation with 
H.pylori 
Correlation with 
H.pylori Cag A cyto-
toxin  
Positive 
Total H. pylori 
Negative 
r P value r P value Total H. pylori 
positive 
Cag A cytotoxin  
 positive  
 Cag A cytotoxin 
negative  
E
n
d
o
s
c
o
p
ic
 f
in
d
in
g
s
 
Pathology 
Location 
Antrum 37 (34.9%) 30 (28.30%) 19 (17.92%) 11 (10.38%) 7 (6.60%) 
0.000 -0.37 0.708 -0.141 0.150 
Body & antrum 6 (5.7%) 5 (4.72%) 5 (4.7%) 0 (0%) 1 (0.94%) 
Multiple 44 (41.5%) 27 (25.47%) 17 (16.04%) 10 (9.43%) 17 (16.04%) 
Duodenum 16 (15.1%) 15 (14.15%) 5 (4.7%) 10 (9.43%) 1 (0.94%) 
Prepyloric 3 (2.8%) 3 (2.83%) 2 (1.89%) 1 (0.94%) 0 (0%) 
Mucosal 
finding 
Normal 12 (11.3%) 11 (10.37%) 7 (6.60%) 4 (3.77%) 1 (0.94%) 
0.000 -0.146 0.136 -0.070 0.477 
Sever erosion 6 (5.7%) 5 (4.72%) 2 (1.89%) 3 (2.83%) 1 (0.94%) 
Inflammation 88 (83.0%) 64 (60.38%) 39 (36.79%) 25 (23.58%) 24 (22.64%) 
Total 106 (100%) 80 (75.47%) 48 (45.28%) 32 (30.18%) 26 (24.53%) 
D
ia
g
n
o
-
s
is
  
Gastric Ulcer 18 (16.98%) 16 (15.09%) 17 (16.04%) 1 (0.94%) 2 (1.89%) 
0.000 -.0372 0.000 -0.372** 0.000 
Gastritis  40 (37.74%) 27 (25.47%) 9 (8.5%) 31 (29.25%) 13 (12.26%) 
Gastropathy  29 (27.36%) 19 (17.92%) 13 (12.26%) 16 (15.1%) 10 (9.43%) 
Duodenal ulcer  13 (12.26%) 12 (12.26%) 7 (6.60%) 6 (5.7%) 1 (0.94%) 
Duodenitis  6 (5.66%) 6 (5.66%) 2 (1.89%) 4 (3.77%) 0 (0%) 
* Correlation is significant at the 0.01 level (2-tailed);**Correlation is significant at the 0.05 level (2-tailed). 
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 No correlation reported between bloating and 
infection with H. pylori Cag A positive (r = -0.097, p 
value = 0.323). 
As shown in Table 5, a total of 88.68% 
patients suffering from multiple pathological finding 
ranged from inflammation 83% to sever erosion 5.7%. 
lesions in antrum represent 34.9% the lesions located 
mainly in antrum in which 28.30% was H. pylori 
positive. Lesions in body and antrum were detected in 
5.7% among them 4.72% H. pylori positive. Multiple 
lesions detected in 41.5%, among them 25.47% were 
H. pylori positive. Duodenal lesions detected in 
15.1%, among them 14.15% were H. pylori positive. 
All prepyloric lesions were H. pylori positive 2.83%. 
Significant difference (p value < 0.001) between 
groups in H. pylori infections. No correlation between 
H. pylori infection and anatomical location (r = -0.37, p 
value = 0.708). No correlation reported between 
location of pathology and infection with H. pylori Cag 
A positive (r = -0.141, p value = 0.150). 
A total of 60.38% of cases with mucosal 
inflammation was H. pylori positive v 4.72% with sever 
erosion and 10.37% normal mucosa. Significant 
difference (p value < 0.001) between groups in H. 
pylori infections, no correlation between H. pylori 
infection and anatomical location (r = -0.146, p value = 
0.136). No correlation was reported between mucosal 
pathology and infection with H. pylori Cag A positive (r 
= -0.070, p value = 0.477), as shown in Table 5. 
H. pylori gastritis detected in 25.47%, 8.5% 
was Cag A positive. H. pylori gastric ulcer detected in 
15.09%, 16.04% was Cag A positive. H. pylori 
gastropathy detected in 17.92%, 12.26% was Cag A 
positive strains. H. pylori duodenal ulcer detected in 
12.26% of patients, 6.60% was Cag A positive. 
Collectively there was significant difference between 
groups regarding H. pylori positivity (p value < 0.001). 
Inverse correlation between endoscopic diagnosis and 
recent H. pylori Infections (r = -.0372, p value < 
0.001). Significant correlation reported between 
endoscopic diagnosis and infection with H. pylori Cag 
A positive (r = -0.372, p value < 0.001) , as shown in 
Table 5.  
 
 
Figure 1: A) In situ hybridization for human gastric ulcer tissue sec-
tion. Staining by BCIP/NBT (bluish purple) counterstained with nu-
clear fast red. Bar size = 50 µm. B) CagA negative expressions in 
normal gastric tissue section 
 
Discussion 
 
In the present study, The prevalence of H. py-
lori infection was 75.47% which was considered high 
compared with neighbours countries such as Saudi 
Arabia 49.8% [13]; Iran 34% [14] to 66.6% [15] while 
in India is 44.23% [16] to 93.3% [17]. The difference in 
H. pylori infection rate may be due to socio economic, 
demographic, cultural factors as well as healthier life-
style differences among communities. 
The mean age of patients was 44.70 years 
which come in accordance with others in Iraq [18]; 
Iran [15] and higher than Turkey 21.14 years [12]. H. 
pylori infection was detected in 22.64% among age 
group 33-41 years, suffered from gastropathy 10.37% 
and gastritis 7.55%. They have 3.77 fold risks to get 
H. pylori infection. CagA cytotoxin was detected in 
16.04%. This come in agreement with a study in 
northern Iraq 22.08% [18]. In India the majority 50.7% 
of H. pylori positive cases at 30-39 years, followed by 
40-49 years (45.9%) [16]. Similar conclusion was re-
ported in Iran [19]. The second age group in H. pylori 
exposure was 24-32 years, in which 15.09% of them 
presented with gastritis 4.72% and gastropathy 
3.77%. They have 2.2 fold to get H. pylori infection 
compared with H. pylori negative gastropathy or gas-
tritis at the same age group. In northern Iraq the 
prevalence among this age group was 39.40% and 
67.5% in other study [20]. In Turkey the prevalence 
among this age group was extremely lower (9.5%) 
[12] while in Iran the prevalence among health care 
workers ˂ 30 years was 30.3% and among those of ≥ 
30 years was 69.7% without significant difference in 
H. pylori exposure among age groups [14]. The third 
age group, which was more exposed to H. pylori was 
69-77 years, suffered from gastric ulcer 6.60% and 
gastritis 4.72%. They have 6.20 fold to get H. pylori 
infection. This result considered extremely higher than 
in India in which only (20%) of patients was H. pylori 
positive at the age ˂70 years [16]. In current study, H. 
pylori Infection were detected in 7.55% among 42-50 
years. Patients suffering from gastropathy were 3.77% 
and gastritis 2.83%. They have 3.4 fold risks to get H. 
pylori infection. In Indian study 42-50 years age group 
exposure to H. pylori infection represent 45.9 % [16]. 
The differences may be due to study design, nature of 
selected population, social and cultural factors.  
H. pylori Infection was detected among 51-59 
years in 6.60%, suffering from gastritis 5.66%, have 
2.14 fold risks to get H. pylori infection. Old ages (78-
86) years were presented with duodenal ulcer (2.83%) 
and they have 7 fold risk to get H. pylori infection. In 
India the prevalence of H. pylori among patients over 
70 years old was 20% [16]. Significant difference was 
detected among age groups in H. pylori infection (p < 
0.001). Positive correlation was reported between age 
groups and H. pylori infection (p value = 0.018). This 
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come in line with others stated that H. pylori exposure 
increased and associated with age [20-22]. This result 
disagree with [14] reported that, no significant differ-
ence and relationship among H. pylori positive pa-
tients and age distribution [14], [23]. 
In current study, no correlation was reported 
between age and infection with Cag A producing H. 
pylori. This come in contrary with others found a 
strong correlation between age groups and infection 
with CagA positive H. pylori [24]. The differences be-
tween countries in H. pylori prevalence; in clinical dis-
ease caused by this pathogen related to the fact that 
prevalence of H. pylori varies widely by geographic 
area, age, race, and ethnicity and socioeconomical 
status as well as due to study design, nature of se-
lected population, social and cultural factors [16]. 
In the present study, males have 1.38 fold risk 
of H. pylori acquisition compared with females with no 
significant differences between males and females (p 
˃ 0.05). There was no correlation between total H. 
pylori infection, CagA+ H. pylori infection and gender 
(p value = 0.492). This come in line with other study in 
the north of Iraq, they found that 47.3% of H. pylori 
positive patients were male versus 41.9% females 
with no significant difference in H. pylori acquisition 
[20]. Same results were reported in Saudi Arabia [22], 
China [25], Iran [14], and Turkey [12]. Although others 
consider female gender as a risk factor for H. pylori 
infection [19]. The reason for the possible gender dif-
ference in H. pylori prevalence is unclear but may be 
related to the frequency of eating in restaurants and 
smoking [22]. 
In this study, people’s residence in rural areas 
has (0.63) fold risk of H. pylori acquisition compared 
with those from urban without significant difference (p 
˃ 0.05). No correlation was reported between total H. 
pylori infection, H. pylori Cag A+ and residency (p 
value = 0.317) (p value = 0. 501). This come in line 
with other study in Iraq [20] and Iran [26]. In Saudi 
Arabia residency in rural areas considered as a risk 
for H. pylori infection [22].The high prevalence of H. 
pylori infection in rural areas may reflect the fact that 
low socioeconomical status and absent of sanitary 
measures beside cultural variation in local community 
may have an important role in this pattern. In the pre-
sent study, there was significant differences between 
smokers infected with H. pylori and those with nega-
tive tests for H. pylori (p ˂ 0.05), although there was 
no correlation between total H. pylori infection, H. py-
lori CagA + and smoking (p value = 0.764). Nonsmok-
ers with positive H. pylori tests represent 47.17% of 
total patients which is higher than in Saudi Arabia [22] 
and less than that reported in India 92.85% [17]. In the 
present study smokers whether (mild, moderate or 
heavy) with positive H. pylori tests constitute 28.30% 
and 16.04% Cag A+ which is less than India 93.75% 
[17] and Saudi Arabia 57.9%. In this study, mild 
smokers have 18 fold risk to get H. pylori infection and 
20.75% were positive for H. pylori, moderate smokers 
have 1.4 fold risk for H. pylori infection and 6.60% 
were H. pylori positive while heavy smokers have one 
fold risk and have 0.94% positive H. pylori. This come 
agreement with local study [18]. The possible mecha-
nism for increase infection among smokers, in general 
may attributed to the destructive effect of smoking on 
the immunity of the gastric mucosa and lining layers, 
hence increasing their susceptibility to infection by H. 
pylori. Communal Shisha smoking might carry the risk 
of passing the infection from a diseased person to an 
uninfected one, in the form of oral infection [22] 
Peoples whose in contact with animals have 
1.52 fold risk of H. pylori acquisition compared with 
those who do not in direct contact with animals with 
significant difference (p ˂ 0.05) although no correla-
tion between H. pylori infection and animals contact (p 
value = 0.431). This result confirmed by Italian study 
referred to detection of H. pylori phosphoglucosamine 
mutase gene in 34.7% of raw goat milk samples [27] 
and in Japan ureA gene of H. pylori was detected in 
72.2% raw milk samples and in 11/20 (55%) commer-
cial pasteurized milk samples [28]. It is clear from pre-
sent results that goat’s or cow’s milk considered as a 
major factor for H. pylori transmission. In addition, 
since the host factor is important in colonization of H. 
pylori in the human, the infection may be established 
in a subset of individuals who drink goat’s or cow’s 
milk. 
Illiterates and patients with primary education 
have 5.36 & 3 fold risk for acquisition of H. pylori in-
fection. While those at secondary and university edu-
cation level have, 0.42 and 1.24 fold risk, respectively 
without significant differences (p ˃ 0.05). Inverse cor-
relation was reported between H. pylori infection and 
education levels (p value = 0.020). This come in 
agreement with others, stated that educated patients 
had a lower frequency of H. pylori infection compared 
with those who were illiterates [29]. Education level 
not necessarily reflects higher socioeconomic status 
for patients and this explanation come in contrary with 
others, indicated that individuals of higher socioeco-
nomic status are often less likely to be infected with H. 
pylori due to hygienic standards of their life styles [30].  
Patients under PPI therapy have 1.02 risk fold 
of H. pylori infection compared with PPI negative with 
significant difference (p ˂ 0.05). No correlation be-
tween PPI intake and H. pylori infection (p value = 
0.968). This finding may be due to the mechanism of 
PPIs which are selectively inhibits the gastric H
+
-
K
+
ATPase and hence gastric acid secretion. All PPIs 
irreversibly inhibits the gastric H
+
-K
+
ATPase by bind-
ing to alpha subunit of the proton pump. Both basal 
and stimulated secretion of gastric acid is inhibited, 
independent of the nature of parietal cell stimulation. 
Gastric acid at pH < 4 has a powerful bactericidal ef-
fect, capable of killing exogenous acid sensitive bacte-
ria introduced in to the stomach usually within 15 min 
[31]. Any increase in the gastric pH above 4 due to 
PPI causes a state of hypochlorhydria and potentially 
increases the susceptibility to various microbes, allow-
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ing at least 50% of ingested bacteria to survive within 
the gastric trap [31]. 
Patients under NSAID therapy have 3.48 fold 
risk of H. pylori infection compared with NSAID nega-
tive cases with significant difference (p ˂ 0.05). No 
correlation between NSAID intake and H. pylori infec-
tion (p value = 0.095). This comes in line with [17], 
stated that no correlation between H. pylori status and 
NSAID intake. Others reported a negative interaction 
between H. pylori and NSAID intake on duodenal ul-
cers suggesting that H. pylori reduces the develop-
ment of these ulcers in NSAID users [32, 33]. Accu-
mulated evidence shows that both aspirin and H. pylo-
ri upregulate the expression of cyclooxygenase 
(COX)-2 at both mRNA and protein levels at the ulcer 
margin. It was, therefore, proposed that H. pylori may 
in fact, antagonize, aspirin-induced delay of ulcer 
healing due to suppression of acid secretion by the 
enhancement in PGE2 possibly derived from COX-2 
expression and activity and to the overexpression of 
growth factors such as TGFα and VEGF [33]. 
Nonalcoholic Patients have 0.75 risk fold of H. 
pylori infection compared with alcoholics with signifi-
cant difference (p ˂ 0.05), without significant correla-
tion between alcohol intake and H. pylori infection (p 
value = 0.056). This comes in line with [17], stated no 
correlation between H. pylori status and alcohol in-
take. In contrary others investigate the association 
between H. pylori and alcohol intake with conflicting 
results [34]. While others considered alcohol con-
sumption a significant independent predictor for H. 
pylori infection [22]. The mechanisms that would pro-
mote an association with alcohol intake were unclear. 
Patients drinking spigot water have 0.45 fold 
to get H. pylori infection compared with filtrated water 
with significant difference (p ˂ 0.05). No correlation 
between drinking of spigot water and H. pylori infec-
tion (p value = 0.236). This comes in line with others 
stated that significant association between the pres-
ence of H. pylori and clinical infection in individuals 
drinking the tap water [35]. Evidence for water as a 
vehicle for transmission has been provided by 
maintenance of H. pylori viability in water [36], amplifi-
cation of H. pylori-specific nucleic acid sequences in 
water [37] and detection of actively respiring H. pylori 
in surface and groundwater [38].  
In current study, no correlation was found be-
tween previous medical history, recent H. pylori Infec-
tions (p value = 0.34), and Cag A positive H. pylori (p 
value = 0.097) which comes in line with [39]. 
Significant difference (p ˂ 0.05) and correla-
tion between weight loss and H. pylori infection (p 
value = 0.001) was reported. This comes in line with 
local study [23] and in contrary with others in Iran [39]. 
In present study significant correlation was reported 
between weight loss and infection with Cag A positive 
H. pylori (p value < 0.001), no current or previous 
study reports this fact. Significant difference (p˂0.05) 
and correlation between heartburn and H. pylori infec-
tion (p value = 0.040) was reported, this comes in 
agreement with other studies in Iraq [23], [29]. Others, 
reported that heartburn was absent after H. pylori 
eradication [40] in contrary, others found no such dif-
ference or correlation [39]. No correlation was re-
ported between heartburn and infection with Cag A 
positive H. pylori (p value = 0.289) which comes in line 
with [41]. Current study was reported significant dif-
ference (p ˂ 0.05) without correlation between epigas-
tric pain and H. pylori infection (p value = 0.114) which 
comes in line with other local study [23]. In Iranian 
study no such difference was detected [39]. No corre-
lation was reported between epigastric pain and infec-
tion with Cag A positive H. pylori (p value = 0.487) 
which comes in accordance with others [41] and in 
contrary with others [29]. 
Current study reported significant difference 
(p ˂ 0.05) without correlation between anemia, H. py-
lori infection (p value = 0.151), and Cag A positive H. 
pylori (p value = 0.091). This comes in line with [42] 
and in contrary with [43, 44] who found significant cor-
relation between iron deficiency anemia and H. pylori. 
As significant difference among H. pylori infected and 
non-infected group present, although no correlation 
was reported with anemia but this reflect the fact that 
the majority of patients suffering from weight loss 
which correlated with the anemic status of patients. 
Significant difference (p ˂ 0.05) without correlation 
between nausea and H. pylori infection was reported 
(p value = 0.358) which comes in line with [23]. No 
correlation was reported between nausea and infec-
tion with Cag A positive H. pylori (p value = 0.660) 
which comes in contrary with [41] [29]. Significant dif-
ference (p ˂ 0.05) without correlation between bloat-
ing and H. pylori infection (p value = 0.341) was re-
ported which comes in line with other [23]. No correla-
tion was reported between bloating and infection with 
Cag A positive H. pylori (p value = 0.323) which come 
in contrary with others [29]. 
In current study, significant difference (p value 
< 0.001) between groups in H. pylori infections without 
correlation between H. pylori infection and anatomical 
location of lesions whether in antrum, body and 
antrum or multiple sites (p value = 0.708), which 
comes in line with [23]. No correlation was reported 
between location of H. pylori associated pathology 
and infection with Cag A positive H. pylori (p value = 
0.150) which comes in contrary with others found 
significant correlation between CagA and gastric and 
duodenal ulcers [45]. No correlation was reported 
between mucosal pathology and infection with Cag A 
positive H. pylori (p value = 0.477) which comes in 
contrary with [45], found significant correlation 
between CagA, gastric and duodenal ulcers. Other 
found that the correlation between H. Pylori, mucosal 
pathology, anatomical location in gut, and the infection 
with H. pylori can be estimated via clinical features of 
infected mucosal lining [46]. Inverse correlation was 
reported between endoscopic diagnosis and recent H. 
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pylori Infections (p value < 0.001). A correlation was 
reported between endoscopic diagnosis and infection 
with Cag A positive H. pylori (p value < 0.001) which 
comes in line with [45, 47].  
In conclusion, several life style factors, 
education, animal contact, using of PPI, and NSAIDs 
increase the risk of H. pylori infection. Weight loss and 
heartburn considered as a cardinal signs for H. pylori 
infection. Endoscopic diagnosis and clinicopa-
thological parameters not strictly associated with 
CagA positivity. 
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